Thomas Engström (Former)
21 – 30 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Subclinical atherosclerosis in patients with cyanotic congenital heart disease
(
- Contribution to journal › Article
-
Mark
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease : A DANAMI-3–PRIMULTI Cardiac Magnetic Resonance Substudy
(
- Contribution to journal › Article
-
Mark
Subsequent Event Risk in Individuals With Established Coronary Heart Disease
(
- Contribution to journal › Article
-
Mark
Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI
(
- Contribution to journal › Article
-
Mark
Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI
(
- Contribution to journal › Article
- 2018
-
Mark
Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
A comprehensive evaluation of the genetic architecture of sudden cardiac arrest
(
- Contribution to journal › Article
-
Mark
Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients
(
- Contribution to journal › Article
-
Mark
Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI : A DANAMI-3 substudy
(
- Contribution to journal › Article